Entries tagged "Talbots"
The euphoric effect that the election hoopla had on Wall Street clearly has subsided, and investors are again reminded that the new guy taking over does not have a magic remedy that will instantaneously make this big economic mess disappear. The Dow Jones Industrial Average plunged 443.48 points on Thursday to close at 8,695.78, bringing the total decline to 10% in the past two days. Abysmal retail sales reports coupled with a Labor Department report Wednesday saying that the number of people continuing to draw unemployment benefits jumped to a 35-year high helped remind the Street of harsh economic realities....
Here's a preview of all of the dealmaking events you need to know about for the week of May 19th. The HSR Act expires for British drug company GlaxoSmithKline's $720 million purchase of Sirtis Pharmaceuticals; Draxis Health shareholders will vote on the proposed merger with drug maker Jubilant; and retailers Target, Home Depot, Limited Brands, Gap, and Talbots will report and discuss earnings. Suzanne Stevens, senior editor of Corporate Dealmaker, joins us this week with a closer look at Talbots' earnings. - The editors...
Earnings season is once again upon us and a few bright spots among Deal Stocks -- such as J.P. Morgan Chase & Co.'s [JPM] better-than-expected first-quarter results -- helped power the markets to significant gains in Wednesday midday trading. The surge may likely be a brief one as fallout from the credit crisis continues with the likes of mortgage lender National City Corp. [NCC] looking for a buyer. Overall, the Dow jumped 184.01, or 1.49%, to 12,546.48 in Wednesday midday trading. The Nasdaq is up 50.71, or 2.22%, to 2,336.75. Here's a closer look at the performance of Deal Stocks...
